The latest version of a microfluidic device for capturing rare circulating tumor cells (CTCs) is the first designed specifically to capture clusters of two or more cells, rather than single cells. The ...
In the medical device industry, there are many ways of measuring success. To be sure, most company leaders take greatest pride in the number of patients whose health has been improved through the use ...
The isolation and analysis of rare CTCs holds great promise for providing insight into blood-borne metastasis, as well as monitoring cancer response noninvasively following therapeutic interventions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results